Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

CD133+ Cell Therapy for Refractory Coronary Heart Disease

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified January 2010 by Hospital y Clinica OCA, S.A. de C.V..
Recruitment status was:  Recruiting
Sponsor:
Information provided by:
Hospital y Clinica OCA, S.A. de C.V.
ClinicalTrials.gov Identifier:
NCT01049867
First received: January 13, 2010
Last updated: NA
Last verified: January 2010
History: No changes posted
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: June 2011
  Estimated Primary Completion Date: December 2010 (Final data collection date for primary outcome measure)